POLISCOPE
Topic57 documents tagged
Finance Signal

Biotechnology

What This Page Covers

This page collects the 57 public records POLISCOPE has tagged with “Biotechnology”. Coverage spans bills, news coverage, and campaign-finance records - each decoded into plain English and linked to its primary source. It most often overlaps with Healthcare, Pharmaceuticals, and Clinical Trials.

Active Bills

Federal BillFEDERALMay 20, 2026HR 5399: Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition ActThe Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition Act (HR 5399) has been introduced to the U.S. House of Representatives and referred to the Subcommittee on ConsFederal BillFEDERALApr 22, 2026Protecting America from Seasonal and Pandemic Influenza Act of 2026Federal BillFEDERALDec 11, 2025House bill creates Department of Defense Biotechnology Management Office to boost bioindustrial manufacturingFederal BillFEDERALJul 15, 2025National Defense Authorization Act for Fiscal Year 2026Federal BillFEDERALSep 17, 2024The ACTIVATE Act: Assessing Adversary Biotechnology CapabilitiesFederal BillFEDERALMay 23, 2024Proposed Office of Biotechnology Policy at the USDA

Recent Activity

  1. Fri, Oct 231 item
    1. Moderna and Merck report mRNA cancer vaccine reduces melanoma recurrence by 42%A personalized mRNA cancer vaccine called intismeran, combined with standard post-surgery treatment, reduced the risk of melanoma returning by 42% over two years compared to standard treatment alone, Hillsborough County2 reports
  2. Mon, Sep 141 item
    1. 858 Therapeutics studies potential breast and ovarian cancer treatmentsClinical-stage drug developer 858 Therapeutics is advancing clinical studies for its lead drug candidate, ETX-19477, targeting breast and ovarian cancer subtypes in patients with BRCA gene mutations.San Diego County
  3. Mon, Aug 311 item
    1. Revelation Biosciences evaluates Gemini drug candidate for kidney disease and infection treatmentsRevelation Biosciences is testing its proprietary drug candidate, Gemini, to treat acute kidney injury, chronic kidney disease, post-surgical infections, and hyperinflammation from severe burns. The cSan Diego County
  4. Wed, Aug 192 items
    1. Moderna and Merck report successful late-stage trial for personalized mRNA melanoma vaccineModerna and Merck announced that their personalized mRNA cancer vaccine, when used alongside the immunotherapy drug Keytruda, reduced the risk of melanoma recurrence or spread in a late-stage clinicalHillsborough County2 reports
    2. Moderna and Merck report positive initial results for experimental mRNA cancer vaccineMiami-Dade County
  5. Mon, Aug 171 item
    1. BlossomHill Therapeutics raises $150 million in Nasdaq initial public offeringBlossomHill Therapeutics launched its initial public offering on the Nasdaq stock exchange on August 7, raising $150 million. The company plans to use the capital to support late-stage clinical studieSan Diego County
  6. Thu, Aug 131 item
    1. FDA Approvals for Gene Therapies Reach Two DozenThe U.S. Food and Drug Administration has approved approximately 24 gene therapies for medical use in the two decades following the Human Genome Project. This sector has expanded into a multi-billion San Diego County
  7. Wed, Aug 121 item
    1. Gossamer Bio prepares to submit first New Drug Application to the FDASan Diego-based biopharmaceutical company Gossamer Bio is nearing the submission of a New Drug Application to the U.S. Food and Drug Administration. This milestone follows a decade of development, mulSan Diego County

Finance Signals

Finance-tagged records
1record associated with this topic
Trace money trail →
LobbyingCHICAGO (COOK COUNTY)Jan 5, 2020
Lobbyist Registration: John Conrad (2020)

Reported financial relationships and timing signals. This does not prove motive or influence.

Key Actors

  1. 01San Diegolocation6 mentions
  2. 02Merckorganization4 mentions
  3. 03Modernaorganization4 mentions
  4. 04Karen Knudsenperson4 mentions
  5. 05Stephen Hogeperson4 mentions
  6. 06Dr. Michael Atkinsperson2 mentions
  7. 07Stephane Bancelperson2 mentions
  8. 08Mr. Fettermanperson2 mentions
  9. 09MD Anderson Cancer Centerorganization2 mentions
  10. 10Madridlocation2 mentions

Connections Preview

Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.

  • Topic to billsHR 5399: Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition Act, Protecting America from Seasonal and Pandemic Influenza Act of 2026, House bill creates Department of Defense Biotechnology Management Office to boost bioindustrial manufacturing (+3 more)
  • Topic to peopleKaren Knudsen, Stephen Hoge, Dr. Michael Atkins (+2 more)
  • Topic to orgsMerck, Moderna, MD Anderson Cancer Center
  • Topic to financeLobbyist Registration: John Conrad (2020)
Open the relationship graph →

Source Trail

Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.

  1. Oct 23, 2026NewsModerna and Merck report mRNA cancer vaccine reduces melanoma recurrence by 42%
  2. Oct 23, 2026NewsModerna and Merck report mRNA cancer vaccine reduces melanoma recurrence by 42%
  3. Sep 14, 2026News858 Therapeutics studies potential breast and ovarian cancer treatments
  4. Aug 31, 2026NewsRevelation Biosciences evaluates Gemini drug candidate for kidney disease and infection treatments
  5. Aug 19, 2026NewsModerna and Merck report successful late-stage trial for personalized mRNA melanoma vaccine
  6. Aug 19, 2026NewsModerna and Merck report successful late-stage trial for personalized mRNA melanoma vaccine
  7. Aug 19, 2026NewsModerna and Merck report positive initial results for experimental mRNA cancer vaccine
  8. Aug 17, 2026NewsBlossomHill Therapeutics raises $150 million in Nasdaq initial public offering
  9. Aug 13, 2026NewsFDA Approvals for Gene Therapies Reach Two Dozen
  10. Aug 12, 2026NewsGossamer Bio prepares to submit first New Drug Application to the FDA

Showing 10 of 57 source records.